Siegfried Holding AGXSWX:SFZN -2.98%96 Days Payable is 37.07 as of Dec. 2025, which is 8% below its 10-year median of 40.10. GuruFocus rates XSWX:SFZN with a GF Score™ of 96/100 and a GF Value™ of CHF91.96 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 920 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 84.57% on this metric.
The historical rank and industry rank for Siegfried Holding AG's Days Payable or its related term are showing as below:
XSWX:SFZN'
s Days Payable Range Over the Past 10 Years
Min: 36 Med: 40.1 Max: 46.9
Current: 38.19
During the past 13 years, Siegfried Holding AG's highest Days Payable was 46.90. The lowest was 36.00. And the median was 40.10.
XSWX:SFZN's Days Payable is ranked worse than 84.57% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs XSWX:SFZN: 38.19
Siegfried Holding AG's Days Payable
increased
from Dec. 2024 (33.71) to Dec. 2025 (37.07).
It may suggest that Siegfried Holding AGdelayed paying its suppliers.
Siegfried Holding AG Days Payable Related Terms
Siegfried Holding AG Days Payable Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SFZN vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Siegfried Holding AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) has a Days Payable of 37.07 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Siegfried Holding AG and its competitors. This is near median its historical median of 40.10. Over the past decade, Siegfried Holding AG's Days Payable has ranged from 36.00 to 46.90. According to the industry distribution chart, Siegfried Holding AG ranks #778 out of 920 companies in the Drug Manufacturers industry, placing it in the top 84.6%.
Is Siegfried Holding AG's Days Payable too high?
Siegfried Holding AG's current Days Payable of 37.07 is near median its 10-year median of 40.10. Over the past 10 years, this metric has ranged from a low of 36.00 to a high of 46.90. The Drug Manufacturers industry median Days Payable is 90.84. Siegfried Holding AG's value of 37.07 is 59.2% below this industry median. Based on the distribution chart, Siegfried Holding AG ranks #778 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Siegfried Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #778 out of 920 companies for Days Payable. This places Siegfried Holding AG in the lower half of its industry. The industry median Days Payable is 90.84. Siegfried Holding AG's value of 37.07 is 59.2% below this benchmark. Historically, Siegfried Holding AG's own Days Payable has ranged from 36.00 to 46.90 over the past decade. While the company's 10-year median is 40.10 vs. the industry median of 90.84, Siegfried Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current Days Payable of 37.07 is 59.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current Days Payable is 37.07, which is near median its own 10-year median of 40.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF91.96, compared to a current price of CHF70.00 — trading 23.9% below its estimated fair value. The current Days Payable is 37.07, which is near median its 10-year median of 40.10 and 59.2% below the Drug Manufacturers industry median of 90.84. Siegfried Holding AG's overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Days Payable is 37.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF70.00 is trading 23.9% below its estimated GF Value™ of CHF91.96.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
Days Payable: 37.07 (near median its 10-year median of 40.10)
GF Value™: CHF91.96 vs. price of CHF70.00 (23.9% below fair value)
Industry Position: 59.2% below the Drug Manufacturers median (#778 of 920)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
96GF Score
Get the complete analysis for XSWX:SFZN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
